Alnylam® International—Sign Up for Email Updates

All fields are required.

First name

Last name

Email address

Country

Medical specialization

Professional designation

I am interested in:

Select all

(Select at least one option)

Transthyretin-mediated amyloidosis (ATTR amyloidosis)

Central Nervous System/Neurodegenerative Diseases
Examples: Alzheimer's, Huntington's, Parkinson's, Amyotrophic Lateral Sclerosis (ALS)

Primary Hyperoxaluria Type 1

Porphyria

Complement-Mediated Diseases
Examples: Atypical Hemolytic Uremic Syndrome (aHUS), Paroxysmal Nocturnal Hemoglobinuria (PNH),
IgA Nephropathy/Berger's

Please note that we will use your preferences to better understand what type of communication you might be interested in and we will make our best effort to accommodate your choices.

By submitting this form, I certify that I am a healthcare professional, and I am 18 years or older. I agree to the Alnylam Privacy Policy and consent to the processing of my personal data per the terms outlined in the Data Privacy Notification and Consent.

I agree to the processing of my personal data by Alnylam and its affiliates (together “Alnylam”), for the purposes of future communications and interactions with Alnylam, by electronic and other means, for medical education, product information, market research and other promotional activities relevant to my medical specialization and, to the extent possible, my professional interests; I understand that my consent is voluntary and can be withdrawn at any time by sending an email to eudataprivacy@alnylam.com.

Optional:

I would like to speak with an Alnylam representative.

All fields are required.

First name

Last name

Email address

Country

I am interested in:

Select all

(Select at least one option)

Transthyretin-mediated amyloidosis (ATTR amyloidosis)

Central Nervous System/Neurodegenerative Diseases
Examples: Alzheimer's, Huntington's, Parkinson's, Amyotrophic Lateral Sclerosis (ALS)

Primary Hyperoxaluria Type 1

Porphyria

Complement-Mediated Diseases
Examples: Atypical Hemolytic Uremic Syndrome (aHUS), Paroxysmal Nocturnal Hemoglobinuria (PNH),
IgA Nephropathy/Berger's

By submitting this form, I agree to the Alnylam Privacy Policy. I am 18 years or older and consent to the processing of my personal data per the terms outlined in the Data Privacy Notification and Consent.

SIGN UP

FOR EMAIL UPDATES

I am a:

I am interested in:

I am interested in:

SIGN UP FOR EMAIL UPDATES

About Alnylam

Our Science

Our Products

Our Pipeline

Medical Professionals

Patients

Investors

Careers